Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tian-En Li"'
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
IntroductionVacuolar protein sorting 29 (VPS29) is a core component of the retromer-retriever complex and is essential for recycling numerous cell-surface cargoes from endosomes. However, there are no reports yet on VPS29 of Eimeria spp.MethodsHere,
Externí odkaz:
https://doaj.org/article/3f8bf0ada6de4cc1ba99d1fe28bccd0d
Autor:
Tian-En Li, Shun Wang, Xiao-Tian Shen, Ze Zhang, Mo Chen, Hao Wang, Ying Zhu, Da Xu, Bei-Yuan Hu, Ran Wei, Yan Zheng, Qiong-Zhu Dong, Lun-Xiu Qin
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Background and AimsPyruvate kinase M2 (PKM2) is an essential regulator of the Warburg effect, but its biological function promoting immune escape of hepatocellular carcinoma (HCC) is unclear.MethodsGEPIA web tool and immunohistochemistry (IHC) analys
Externí odkaz:
https://doaj.org/article/42966a4e96e44c70ad617d760a2738c3
Autor:
Beiyuan Hu, Tiantian Zou, Wei Qin, Xiaotian Shen, Yinghan Su, Jianhua Li, Yang Chen, Ze Zhang, Haoting Sun, Yan Zheng, Chao-Qun Wang, Zhengxin Wang, Tian-En Li, Shun Wang, Le Zhu, Xufeng Wang, Yan Fu, Xudong Ren, Qiongzhu Dong, Lun-Xiu Qin
Publikováno v:
Cancer Research. 82:3845-3857
Lenvatinib is an inhibitor of multiple receptor tyrosine kinases that was recently authorized for first-line treatment of hepatocellular carcinoma (HCC). However, the clinical benefits derived from lenvatinib are limited, highlighting the urgent need
Autor:
Ying Zhu, Mo Chen, Da Xu, Tian-En Li, Ze Zhang, Jian-Hua Li, Xiang-Yu Wang, Xin Yang, Lu Lu, Hu-Liang Jia, Qiong-Zhu Dong, Lun-Xiu Qin
Publikováno v:
Cell Mol Immunol
BACKGROUND: The efficacy of immune checkpoint inhibitors (ICIs), such as programmed cell death protein-1 (PD-1) or its ligand 1 (PD-L1) antibody, in hepatocellular carcinoma (HCC) is limited, and it is recommended that they be combined with other the
Autor:
Lun-Xiu Qin, Qiongzhu Dong, Xudong Ren, Yan Fu, Xufeng Wang, Le Zhu, Shun Wang, Tian-En Li, Zhengxin Wang, Chao-Qun Wang, Yan Zheng, Haoting Sun, Ze Zhang, Yang Chen, Jianhua Li, Yinghan Su, Xiaotian Shen, Wei Qin, Tiantian Zou, Beiyuan Hu
Lenvatinib is an inhibitor of multiple receptor tyrosine kinases that was recently authorized for first-line treatment of hepatocellular carcinoma (HCC). However, the clinical benefits derived from lenvatinib are limited, highlighting the urgent need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c447e6f4d25e26f09a48e9397553462c
https://doi.org/10.1158/0008-5472.c.6514100.v1
https://doi.org/10.1158/0008-5472.c.6514100.v1
Autor:
Lun-Xiu Qin, Qiongzhu Dong, Xudong Ren, Yan Fu, Xufeng Wang, Le Zhu, Shun Wang, Tian-En Li, Zhengxin Wang, Chao-Qun Wang, Yan Zheng, Haoting Sun, Ze Zhang, Yang Chen, Jianhua Li, Yinghan Su, Xiaotian Shen, Wei Qin, Tiantian Zou, Beiyuan Hu
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff03b77db3a224b0370fdfbee69da17
https://doi.org/10.1158/0008-5472.22432256.v1
https://doi.org/10.1158/0008-5472.22432256.v1
Autor:
Tian-En Li, Jimeng Yang, Bei-Yuan Hu, Da Xu, Qiongzhu Dong, Chaoqun Wang, Ze Zhang, Feng Yang, Christiane Bruns, Shican Yan, Peter J. Nelson, Min Xue, Yan Zheng, Deliang Fu, Hu-Liang Jia, Yue Zhao, Lun-Xiu Qin, Xuan Wang, Chao Wu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-14 (2020)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
Enolase 2 (ENO2) is a key glycolytic enzyme in the metabolic process of glycolysis, but its potential function in pancreatic ductal adenocarcinoma (PDAC) is unclear. In this study, we observed a significant overexpression of ENO2 in PDAC tissues, and
Publikováno v:
Aging (Albany NY)
Objectives: Breast cancer has been the second most prevalent and fatal malignancy due to its frequent metastasis to other organs. We aim to study the effects of a key miRNA-mRNA signaling in breast cancer. Results: CNN1 was identified as the key gene
Autor:
Xin-Yuan Ding, Zheng Wang, Yan-Feng Liu, Yuhao Gao, Wenjuan Wang, Kun-Wei Shen, Haoyu Wang, Xiao-Song Chen, Fan Wang, Tian-En Li
Publikováno v:
Cancer letters. 527
Background: Growing evidence suggests that the bidirectional interactions between cancer cells and their surrounding environment namely the tumor microenvironment (TME), contributes to cancer progression, metastasis, and resistance to treatment. Inte
Autor:
Junjie Pan, Yan Zheng, Song Gao, Bei-Yuan Hu, Qiongzhu Dong, Ying Zhu, Tian-En Li, Chao Wu, Xuan Wang, Mo Chen, Lu Lu, Hu-Liang Jia, Ze Zhang, Lun-Xiu Qin, Zhifei Lin, Da Xu
Publikováno v:
British Journal of Cancer
Background Mitochondrial dynamics plays an important role in tumour progression. However, how these dynamics integrate tumour metabolism in hepatocellular carcinoma (HCC) metastasis is still unclear. Methods The mitochondrial fusion protein mitofusin